These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
503 related articles for article (PubMed ID: 20951943)
1. Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase. Aggarwal P; Vaites LP; Kim JK; Mellert H; Gurung B; Nakagawa H; Herlyn M; Hua X; Rustgi AK; McMahon SB; Diehl JA Cancer Cell; 2010 Oct; 18(4):329-40. PubMed ID: 20951943 [TBL] [Abstract][Full Text] [Related]
2. PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers. Li Y; Chitnis N; Nakagawa H; Kita Y; Natsugoe S; Yang Y; Li Z; Wasik M; Klein-Szanto AJ; Rustgi AK; Diehl JA Cancer Discov; 2015 Mar; 5(3):288-303. PubMed ID: 25582697 [TBL] [Abstract][Full Text] [Related]
3. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing. Chung J; Karkhanis V; Tae S; Yan F; Smith P; Ayers LW; Agostinelli C; Pileri S; Denis GV; Baiocchi RA; Sif S J Biol Chem; 2013 Dec; 288(49):35534-47. PubMed ID: 24189068 [TBL] [Abstract][Full Text] [Related]
4. The Fbx4 tumor suppressor regulates cyclin D1 accumulation and prevents neoplastic transformation. Vaites LP; Lee EK; Lian Z; Barbash O; Roy D; Wasik M; Klein-Szanto AJ; Rustgi AK; Diehl JA Mol Cell Biol; 2011 Nov; 31(22):4513-23. PubMed ID: 21911473 [TBL] [Abstract][Full Text] [Related]
5. Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells. Wang L; Pal S; Sif S Mol Cell Biol; 2008 Oct; 28(20):6262-77. PubMed ID: 18694959 [TBL] [Abstract][Full Text] [Related]
6. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression. Chen H; Lorton B; Gupta V; Shechter D Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440 [TBL] [Abstract][Full Text] [Related]
7. Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication. Aggarwal P; Lessie MD; Lin DI; Pontano L; Gladden AB; Nuskey B; Goradia A; Wasik MA; Klein-Szanto AJ; Rustgi AK; Bassing CH; Diehl JA Genes Dev; 2007 Nov; 21(22):2908-22. PubMed ID: 18006686 [TBL] [Abstract][Full Text] [Related]
8. Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma. Karkhanis V; Alinari L; Ozer HG; Chung J; Zhang X; Sif S; Baiocchi RA J Biol Chem; 2020 Jan; 295(5):1165-1180. PubMed ID: 31822509 [TBL] [Abstract][Full Text] [Related]
9. Methylosome Protein 50 and PKCδ/p38δ Protein Signaling Control Keratinocyte Proliferation via Opposing Effects on p21Cip1 Gene Expression. Saha K; Eckert RL J Biol Chem; 2015 May; 290(21):13521-30. PubMed ID: 25851901 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. Lin DI; Barbash O; Kumar KG; Weber JD; Harper JW; Klein-Szanto AJ; Rustgi A; Fuchs SY; Diehl JA Mol Cell; 2006 Nov; 24(3):355-66. PubMed ID: 17081987 [TBL] [Abstract][Full Text] [Related]
11. Location, location, location: the role of cyclin D1 nuclear localization in cancer. Gladden AB; Diehl JA J Cell Biochem; 2005 Dec; 96(5):906-13. PubMed ID: 16163738 [TBL] [Abstract][Full Text] [Related]
12. Histone H2A and H4 N-terminal tails are positioned by the MEP50 WD repeat protein for efficient methylation by the PRMT5 arginine methyltransferase. Burgos ES; Wilczek C; Onikubo T; Bonanno JB; Jansong J; Reimer U; Shechter D J Biol Chem; 2015 Apr; 290(15):9674-89. PubMed ID: 25713080 [TBL] [Abstract][Full Text] [Related]
13. PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma. Yang H; Zhao X; Zhao L; Liu L; Li J; Jia W; Liu J; Huang G Oncotarget; 2016 Nov; 7(44):72131-72147. PubMed ID: 27708221 [TBL] [Abstract][Full Text] [Related]
14. Cyclin D1, cancer progression, and opportunities in cancer treatment. Qie S; Diehl JA J Mol Med (Berl); 2016 Dec; 94(12):1313-1326. PubMed ID: 27695879 [TBL] [Abstract][Full Text] [Related]
15. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Benzeno S; Lu F; Guo M; Barbash O; Zhang F; Herman JG; Klein PS; Rustgi A; Diehl JA Oncogene; 2006 Oct; 25(47):6291-303. PubMed ID: 16732330 [TBL] [Abstract][Full Text] [Related]
16. Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer. Barbash O; Zamfirova P; Lin DI; Chen X; Yang K; Nakagawa H; Lu F; Rustgi AK; Diehl JA Cancer Cell; 2008 Jul; 14(1):68-78. PubMed ID: 18598945 [TBL] [Abstract][Full Text] [Related]
17. Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis. Wei TY; Hsia JY; Chiu SC; Su LJ; Juan CC; Lee YC; Chen JM; Chou HY; Huang JY; Huang HM; Yu CT Cell Signal; 2014 Dec; 26(12):2940-50. PubMed ID: 25277535 [TBL] [Abstract][Full Text] [Related]
18. Multiple cullin-associated E3 ligases regulate cyclin D1 protein stability. Lu K; Zhang M; Wei G; Xiao G; Tong L; Chen D Elife; 2023 Nov; 12():. PubMed ID: 37943017 [TBL] [Abstract][Full Text] [Related]
19. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Pal S; Vishwanath SN; Erdjument-Bromage H; Tempst P; Sif S Mol Cell Biol; 2004 Nov; 24(21):9630-45. PubMed ID: 15485929 [TBL] [Abstract][Full Text] [Related]
20. A jumonji (Jarid2) protein complex represses cyclin D1 expression by methylation of histone H3-K9. Shirato H; Ogawa S; Nakajima K; Inagawa M; Kojima M; Tachibana M; Shinkai Y; Takeuchi T J Biol Chem; 2009 Jan; 284(2):733-9. PubMed ID: 19010785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]